Estimaciones de analistas de Wall Street para Henry Schein, Inc. (HSIC): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 17 |
| Mantener | 14 |
| Venta | 3 |
| Venta fuerte | 0 |
| Analistas totales | 34 |
| Calificación media (1-5) | 0.41 |
Ratios de valoración
| Ratio P/E | 25.08 |
| Precio / Valor contable | 3.12 |
| EV / EBITDA | 13.13 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $11.57B | $12.46B | $13.20B | $9.99B | $10.12B | $12.40B | $12.65B | $12.34B | $12.67B | $13.18B |
| Coste de Ventas | $8.35B | $9.06B | $6.51B | $6.89B | $7.30B | $8.73B | $9.00B | $8.69B | $8.91B | $9.34B |
| Beneficio Bruto | $3.23B | $3.40B | $2.91B | $3.09B | $2.81B | $3.67B | $3.65B | $3.65B | $3.77B | $3.84B |
| I+D | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | $2.41B | $2.53B | $2.22B | $2.36B | $2.25B | $2.82B | $2.71B | $2.94B | $3.04B | $3.08B |
| Gastos Operativos | $2.41B | $2.53B | $2.22B | $2.36B | $2.25B | $2.82B | $2.71B | $2.94B | $3.04B | $3.08B |
| Beneficio Operativo | $817.5M | $864.7M | $693.5M | $733.0M | $567.4M | $854.8M | $938.0M | $714.0M | $729.0M | $758.0M |
| EBITDA | $957.5M | $1.07B | $756.5M | $916.0M | $726.8M | $1.07B | $977.0M | $877.0M | $941.0M | $1.01B |
| Gastos por Intereses | $31.9M | $53.7M | $76.0M | $50.8M | $41.4M | $27.6M | $44.0M | $87.0M | $131.0M | $150.0M |
| Beneficio Antes de Impuestos | $774.4M | $821.8M | $557.9M | $698.2M | $512.2M | $850.6M | $736.0M | $556.0M | $526.0M | $545.0M |
| Impuestos | $218.0M | $362.5M | $107.4M | $159.5M | $95.4M | $197.3M | $170.0M | $120.0M | $128.0M | $126.0M |
| Beneficio Neto | $506.8M | $406.3M | $535.9M | $508.0M | $402.2M | $623.9M | $538.0M | $416.0M | $390.0M | $398.0M |
| BPA | $3.16 | $2.59 | $3.51 | $3.44 | $2.82 | $4.51 | $3.95 | $3.18 | $3.07 | $3.29 |
| BPA Diluido | $3.12 | $2.57 | $3.49 | $3.40 | $2.80 | $4.45 | $3.91 | $3.16 | $3.05 | $3.27 |
| Acciones en Circulación (Diluidas) | $162.4M | $158.2M | $153.7M | $149.3M | $143.4M | $141.8M | $137.8M | $131.7M | $127.8M | $121.7M |
Precio
| Precio | $87.30 |
| Capitalización | $9.9B |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ATR · AVTR · BIO · DVA · GMED · GRFS · HALO
Explorar sector: Healthcare · Medical - Distribution
Más secciones de HSIC: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones